跳到正文

Trevi Therapeutics, Inc.(TRVI)内部人交易:高管与董事近期交易

过去 18 个月,共有 12 位内部人为 Trevi Therapeutics, Inc.(TRVI)报告了 17 笔 Form 4 交易(最近一笔 2026-09-17)。

日期内部人职务类型股数市值
2026-09-17Heffernan Michael Thomas董事买入18,421$56,000
2026-09-17Heffernan Michael Thomas董事卖出18,321$276,464
2026-09-17Heffernan Michael Thomas董事卖出100$1,588
2026-09-17Heffernan Michael Thomas董事买入21,052$70,103
2026-09-17Heffernan Michael Thomas董事卖出20,952$316,166
2026-09-17Heffernan Michael Thomas董事卖出100$1,588
2026-02-13New Enterprise Associates 16, L.P.10% 以上股东买入1.9M$2.5M
2026-02-13NEA Partners 16, L.P.10% 以上股东买入1.9M$2.5M
2026-02-13NEA 16 GP, LLC10% 以上股东买入1.9M$2.5M
2026-02-13Makhzoumi Mohamad10% 以上股东买入1.9M$2.5M
2026-02-13Chang Carmen10% 以上股东买入1.9M$2.5M
2026-02-13Behbahani Ali10% 以上股东买入1.9M$2.5M
2026-02-13Florence Anthony A. Jr.10% 以上股东买入1.9M$2.5M
2026-02-13Walker Paul Edward10% 以上股东买入1.9M$2.5M
2026-02-13BASKETT FOREST10% 以上股东买入1.9M$2.5M
2026-02-13SANDELL SCOTT D10% 以上股东买入1.9M$2.5M
2025-12-03Galletta ChristopherController and Principal Accounting Officer买入4,225$2,155

来源:SEC Form 4 申报文件 · 截至 2026-09-17